TGC Ventures International, Inc. (TGVN) Research
TGC Ventures International, Inc. operates clinics dedicated to the prompt identification of cancer, leveraging infra-red thermal imaging technology. This diagnostic method is crucial for discerning tissue anomalies and is specifically utilized in the detection of breast cancer. Established in 2003 and headquartered in Atlanta, Georgia, the company adopted its current identity, TGC Ventures International, Inc., in December 2005, having previously been known as National Detection Clinics, Ltd.
Market snapshot
- Symbol
- TGVN
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $120.0
- 52-week range
- 1.0E-4-1.0E-4
- Sector
- Healthcare
- Industry
- Medical - Distribution
Peer companies
Open TGC Ventures International, Inc. (TGVN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.